Share Price and Basic Stock Data
Last Updated: October 8, 2025, 11:22 pm
PEG Ratio | 30.44 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Aplab Ltd, operating in the Instrumentation & Process Control sector, has a market capitalization of ₹171 Cr. The company reported a Price-to-Earnings (P/E) ratio of 169, indicating investor confidence and growth potential. Quarterly sales trends reveal a consistent pattern, with a gradual increase in revenue over the past few quarters. Operating Profit Margin (OPM) stands at 11.26%, reflecting operational efficiency. Despite facing challenges, Aplab Ltd has managed to maintain a stable revenue stream, showcasing resilience in a competitive market.
Profitability and Efficiency Metrics
With a Return on Equity (ROE) of 2.95% and Return on Capital Employed (ROCE) of 8.82%, Aplab Ltd demonstrates moderate profitability. The Net Profit margin of 0.26% suggests tight cost control measures. However, the Interest Coverage Ratio (ICR) of -0.39x indicates financial strain due to high borrowings. The Cash Conversion Cycle (CCC) of 219.18 days highlights potential liquidity challenges. Aplab Ltd needs to focus on enhancing operational efficiency and exploring avenues for margin improvement to boost profitability.
Balance Sheet Strength and Financial Ratios
Aplab Ltd’s negative reserves of -₹2.20 Cr raise concerns about its financial health and ability to withstand economic uncertainties. The borrowings of ₹29.94 Cr signify reliance on external funding sources. The Price-to-Book Value (P/BV) ratio of -2.24x reflects undervaluation in the market. Improving working capital management and reducing debt levels are critical for strengthening the balance sheet and enhancing investor confidence.
Shareholding Pattern and Investor Confidence
Promoters hold a significant stake of 37.35%, indicating a vested interest in the company’s performance. Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) have limited exposure, with DIIs holding a marginal 0.01% stake. The increasing public shareholding of 62.66% suggests a broader investor base. Changes in the shareholding pattern can impact the company’s valuation and market sentiment, influencing its overall competitiveness and growth prospects.
Outlook, Risks, and Final Insight
Looking ahead, Aplab Ltd must focus on diversifying revenue streams and enhancing operational efficiency to drive growth. Key growth drivers include technological advancements, strategic partnerships, and market expansion. However, risks such as economic downturns, regulatory challenges, and intense competition pose significant threats to the company’s performance. Strengthening financial resilience, improving profitability, and fostering investor trust are crucial for navigating uncertainties and achieving long-term sustainability in the market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Aplab Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Aplab Ltd | 165 Cr. | 74.8 | 84.4/28.2 | 164 | 4.14 | 0.00 % | 8.82 % | 2.95 % | 10.0 |
Industry Average | 165.00 Cr | 74.80 | 164.00 | 4.14 | 0.00% | 8.82% | 2.95% | 10.00 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 10.89 | 10.56 | 11.54 | 18.49 | 9.11 | 10.88 | 11.93 | 17.61 | 9.93 | 13.86 | 15.94 | 23.93 | 15.45 |
Expenses | 12.12 | 11.49 | 10.54 | 11.27 | 8.34 | 9.34 | 11.19 | 15.88 | 9.10 | 13.26 | 23.94 | 25.33 | 13.71 |
Operating Profit | -1.23 | -0.93 | 1.00 | 7.22 | 0.77 | 1.54 | 0.74 | 1.73 | 0.83 | 0.60 | -8.00 | -1.40 | 1.74 |
OPM % | -11.29% | -8.81% | 8.67% | 39.05% | 8.45% | 14.15% | 6.20% | 9.82% | 8.36% | 4.33% | -50.19% | -5.85% | 11.26% |
Other Income | -1.44 | 0.07 | -0.41 | 0.06 | 0.06 | 0.06 | 0.05 | -0.03 | 0.06 | 1.88 | 0.46 | 2.69 | 0.19 |
Interest | 0.67 | 0.66 | 0.75 | 0.93 | 0.67 | 1.35 | 0.33 | 1.09 | 0.67 | 0.82 | 0.77 | 0.95 | 0.68 |
Depreciation | 0.12 | 0.12 | 0.12 | 0.08 | 0.14 | 0.11 | 0.08 | 0.12 | 0.12 | 0.13 | 0.10 | 0.13 | 0.12 |
Profit before tax | -3.46 | -1.64 | -0.28 | 6.27 | 0.02 | 0.14 | 0.38 | 0.49 | 0.10 | 1.53 | -8.41 | 0.21 | 1.13 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,252.38% | 24.78% |
Net Profit | -3.46 | -1.64 | -0.28 | 6.27 | 0.02 | 0.14 | 0.38 | 0.49 | 0.10 | 1.53 | -8.41 | 7.04 | 0.85 |
EPS in Rs | -1.73 | -0.82 | -0.14 | 3.14 | 0.01 | 0.06 | 0.17 | 0.22 | 0.05 | 0.69 | -3.35 | 2.80 | 0.34 |
Last Updated: August 19, 2025, 11:35 pm
Below is a detailed analysis of the quarterly data for Aplab Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 15.45 Cr.. The value appears to be declining and may need further review. It has decreased from 23.93 Cr. (Mar 2025) to 15.45 Cr., marking a decrease of 8.48 Cr..
- For Expenses, as of Jun 2025, the value is 13.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.33 Cr. (Mar 2025) to 13.71 Cr., marking a decrease of 11.62 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.74 Cr.. The value appears strong and on an upward trend. It has increased from -1.40 Cr. (Mar 2025) to 1.74 Cr., marking an increase of 3.14 Cr..
- For OPM %, as of Jun 2025, the value is 11.26%. The value appears strong and on an upward trend. It has increased from -5.85% (Mar 2025) to 11.26%, marking an increase of 17.11%.
- For Other Income, as of Jun 2025, the value is 0.19 Cr.. The value appears to be declining and may need further review. It has decreased from 2.69 Cr. (Mar 2025) to 0.19 Cr., marking a decrease of 2.50 Cr..
- For Interest, as of Jun 2025, the value is 0.68 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.95 Cr. (Mar 2025) to 0.68 Cr., marking a decrease of 0.27 Cr..
- For Depreciation, as of Jun 2025, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.13 Cr. (Mar 2025) to 0.12 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.13 Cr.. The value appears strong and on an upward trend. It has increased from 0.21 Cr. (Mar 2025) to 1.13 Cr., marking an increase of 0.92 Cr..
- For Tax %, as of Jun 2025, the value is 24.78%. The value appears to be increasing, which may not be favorable. It has increased from -3,252.38% (Mar 2025) to 24.78%, marking an increase of 3,277.16%.
- For Net Profit, as of Jun 2025, the value is 0.85 Cr.. The value appears to be declining and may need further review. It has decreased from 7.04 Cr. (Mar 2025) to 0.85 Cr., marking a decrease of 6.19 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.34. The value appears to be declining and may need further review. It has decreased from 2.80 (Mar 2025) to 0.34, marking a decrease of 2.46.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:58 pm
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 94.86 | 74.18 | 70.89 | 72.04 | 61.03 | 53.19 | 51.47 | 53.02 | 51.36 | 51.48 | 49.05 | 63.67 |
Expenses | 82.20 | 76.93 | 76.44 | 74.36 | 65.02 | 55.68 | 47.45 | 47.75 | 44.42 | 45.27 | 44.51 | 71.64 |
Operating Profit | 12.66 | -2.75 | -5.55 | -2.32 | -3.99 | -2.49 | 4.02 | 5.27 | 6.94 | 6.21 | 4.54 | -7.97 |
OPM % | 13.35% | -3.71% | -7.83% | -3.22% | -6.54% | -4.68% | 7.81% | 9.94% | 13.51% | 12.06% | 9.26% | -12.52% |
Other Income | 0.93 | 0.71 | 0.82 | 1.55 | 0.38 | 18.50 | 3.42 | 1.32 | -1.08 | -1.72 | 0.15 | 5.09 |
Interest | 10.22 | 10.63 | 11.24 | 11.21 | 10.82 | 8.06 | 6.21 | 6.60 | 5.31 | 3.84 | 3.45 | 3.20 |
Depreciation | 2.78 | 1.76 | 1.62 | 1.56 | 1.44 | 1.29 | 1.02 | 0.38 | 0.38 | 0.45 | 0.44 | 0.49 |
Profit before tax | 0.59 | -14.43 | -17.59 | -13.54 | -15.87 | 6.66 | 0.21 | -0.39 | 0.17 | 0.20 | 0.80 | -6.57 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -103.96% |
Net Profit | 0.59 | -14.43 | -17.59 | -13.54 | -15.87 | 5.41 | 0.21 | -0.39 | 0.17 | 0.20 | 0.80 | 0.26 |
EPS in Rs | 0.30 | -7.22 | -8.80 | -6.77 | -7.94 | 2.70 | 0.10 | -0.20 | 0.08 | 0.10 | 0.36 | 0.10 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -2545.76% | -21.90% | 23.02% | -17.21% | 134.09% | -96.12% | -285.71% | 143.59% | 17.65% | 300.00% | -67.50% |
Change in YoY Net Profit Growth (%) | 0.00% | 2523.86% | 44.92% | -40.23% | 151.30% | -230.21% | -189.60% | 429.30% | -125.94% | 282.35% | -367.50% |
Aplab Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | -2% |
5 Years: | 4% |
3 Years: | 7% |
TTM: | 37% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | 16% |
3 Years: | -45% |
TTM: | -42% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 61% |
3 Years: | 73% |
1 Year: | 22% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 3% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: October 10, 2025, 3:28 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 10.00 | 10.00 | 11.09 | 12.57 |
Reserves | 21.84 | 7.02 | -10.57 | -23.03 | -37.54 | -31.64 | -31.38 | -31.08 | -30.76 | -29.81 | -3.83 | -2.19 |
Borrowings | 74.85 | 72.78 | 71.71 | 66.30 | 70.28 | 70.20 | 71.36 | 71.71 | 47.62 | 50.24 | 28.84 | 29.93 |
Other Liabilities | 48.83 | 42.05 | 65.49 | 70.61 | 68.55 | 59.67 | 48.54 | 43.90 | 39.54 | 45.08 | 35.24 | 29.65 |
Total Liabilities | 150.52 | 126.85 | 131.63 | 118.88 | 106.29 | 103.23 | 93.52 | 89.53 | 66.40 | 75.51 | 71.34 | 69.96 |
Fixed Assets | 57.68 | 55.04 | 53.33 | 51.61 | 16.78 | 4.26 | 3.70 | 3.47 | 6.54 | 7.37 | 7.03 | 6.72 |
CWIP | 0.00 | 0.00 | 0.00 | 0.35 | 0.82 | 2.35 | 3.59 | 3.88 | 1.08 | 0.00 | 0.49 | 1.21 |
Investments | 2.26 | 0.07 | 0.07 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
Other Assets | 90.58 | 71.74 | 78.23 | 66.90 | 88.67 | 96.60 | 86.21 | 82.16 | 58.76 | 68.12 | 63.80 | 62.00 |
Total Assets | 150.52 | 126.85 | 131.63 | 118.88 | 106.29 | 103.23 | 93.52 | 89.53 | 66.40 | 75.51 | 71.34 | 69.96 |
Below is a detailed analysis of the balance sheet data for Aplab Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 12.57 Cr.. The value appears strong and on an upward trend. It has increased from 11.09 Cr. (Mar 2024) to 12.57 Cr., marking an increase of 1.48 Cr..
- For Reserves, as of Mar 2025, the value is -2.19 Cr.. The value appears to be improving (becoming less negative). It has improved from -3.83 Cr. (Mar 2024) to -2.19 Cr., marking an improvement of 1.64 Cr..
- For Borrowings, as of Mar 2025, the value is 29.93 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 28.84 Cr. (Mar 2024) to 29.93 Cr., marking an increase of 1.09 Cr..
- For Other Liabilities, as of Mar 2025, the value is 29.65 Cr.. The value appears to be improving (decreasing). It has decreased from 35.24 Cr. (Mar 2024) to 29.65 Cr., marking a decrease of 5.59 Cr..
- For Total Liabilities, as of Mar 2025, the value is 69.96 Cr.. The value appears to be improving (decreasing). It has decreased from 71.34 Cr. (Mar 2024) to 69.96 Cr., marking a decrease of 1.38 Cr..
- For Fixed Assets, as of Mar 2025, the value is 6.72 Cr.. The value appears to be declining and may need further review. It has decreased from 7.03 Cr. (Mar 2024) to 6.72 Cr., marking a decrease of 0.31 Cr..
- For CWIP, as of Mar 2025, the value is 1.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.49 Cr. (Mar 2024) to 1.21 Cr., marking an increase of 0.72 Cr..
- For Investments, as of Mar 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Mar 2024) to 0.03 Cr., marking an increase of 0.01 Cr..
- For Other Assets, as of Mar 2025, the value is 62.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.80 Cr. (Mar 2024) to 62.00 Cr., marking a decrease of 1.80 Cr..
- For Total Assets, as of Mar 2025, the value is 69.96 Cr.. The value appears to be declining and may need further review. It has decreased from 71.34 Cr. (Mar 2024) to 69.96 Cr., marking a decrease of 1.38 Cr..
However, the Borrowings (29.93 Cr.) are higher than the Reserves (-2.19 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -62.19 | -75.53 | -77.26 | -68.62 | -74.27 | -72.69 | -67.34 | -66.44 | -40.68 | -44.03 | -24.30 | -37.90 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 109.66 | 90.00 | 102.77 | 88.92 | 36.42 | 131.89 | 134.24 | 104.71 | 124.51 | 212.92 | 169.22 | 124.51 |
Inventory Days | 288.61 | 275.19 | 152.39 | 102.72 | 168.84 | 184.91 | 301.69 | 243.23 | 300.66 | 544.09 | 663.21 | 193.62 |
Days Payable | 198.46 | 103.01 | 192.21 | 18.98 | 156.27 | 152.70 | 164.50 | 167.18 | 129.08 | 194.05 | 190.71 | 98.96 |
Cash Conversion Cycle | 199.81 | 262.18 | 62.95 | 172.66 | 48.99 | 164.11 | 271.42 | 180.76 | 296.09 | 562.96 | 641.72 | 219.18 |
Working Capital Days | -122.51 | -170.15 | -426.01 | -462.58 | -255.08 | -276.61 | -328.98 | -320.05 | -293.58 | -194.91 | 3.13 | -17.26 |
ROCE % | 11.00% | -4.08% | -8.40% | -4.91% | -11.74% | -8.51% | 7.41% | 13.71% | 18.98% | 21.64% | 14.91% | -8.82% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.61 |
Diluted EPS (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.61 |
Cash EPS (Rs.) | -31.37 | -24.41 | 7.54 | -23.24 | 1.60 |
Book Value[Excl.RevalReserv]/Share (Rs.) | -8.81 | 26.34 | 55.53 | 47.41 | 43.80 |
Book Value[Incl.RevalReserv]/Share (Rs.) | -8.77 | 26.39 | 55.59 | 47.47 | 44.03 |
Revenue From Operations / Share (Rs.) | 142.20 | 149.14 | 191.06 | 142.68 | 194.29 |
PBDIT / Share (Rs.) | -8.88 | -3.06 | 28.21 | -5.09 | 19.70 |
PBIT / Share (Rs.) | -12.66 | -7.08 | 22.36 | -9.97 | 14.50 |
PBT / Share (Rs.) | -35.14 | -28.33 | 1.91 | -28.17 | -3.48 |
Net Profit / Share (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.59 |
NP After MI And SOA / Share (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.59 |
PBDIT Margin (%) | -6.24 | -2.05 | 14.76 | -3.56 | 10.13 |
PBIT Margin (%) | -8.90 | -4.74 | 11.70 | -6.99 | 7.46 |
PBT Margin (%) | -24.70 | -18.99 | 1.00 | -19.74 | -1.79 |
Net Profit Margin (%) | -24.71 | -19.05 | 0.88 | -19.70 | -1.85 |
NP After MI And SOA Margin (%) | -24.71 | -19.05 | 0.88 | -19.70 | -1.85 |
Return on Networth / Equity (%) | 0.00 | -112.18 | 3.09 | -60.09 | -8.24 |
Return on Capital Employeed (%) | -87.40 | -8.90 | 22.07 | -10.19 | 21.15 |
Return On Assets (%) | -13.14 | -11.07 | 0.56 | -10.59 | -1.53 |
Long Term Debt / Equity (X) | 0.00 | 0.58 | 0.46 | 0.57 | 0.43 |
Total Debt / Equity (X) | -16.98 | 5.50 | 2.67 | 2.90 | 2.75 |
Asset Turnover Ratio (%) | 0.54 | 0.53 | 0.67 | 0.57 | 0.81 |
Current Ratio (X) | 0.39 | 0.57 | 0.67 | 0.74 | 0.96 |
Quick Ratio (X) | 0.24 | 0.20 | 0.31 | 0.22 | 0.34 |
Inventory Turnover Ratio (X) | 1.65 | 1.25 | 1.24 | 0.68 | 1.19 |
Interest Coverage Ratio (X) | -0.39 | -0.14 | 1.38 | -0.27 | 1.10 |
Interest Coverage Ratio (Post Tax) (X) | -0.56 | -0.33 | 1.08 | -0.56 | 0.80 |
Enterprise Value (Cr.) | 88.89 | 87.10 | 88.96 | 75.60 | 70.92 |
EV / Net Operating Revenue (X) | 1.25 | 1.17 | 0.93 | 1.06 | 0.73 |
EV / EBITDA (X) | -20.01 | -56.88 | 6.31 | -29.70 | 7.20 |
MarketCap / Net Operating Revenue (X) | 0.15 | 0.19 | 0.16 | 0.15 | 0.13 |
Price / BV (X) | -2.24 | 1.16 | 0.57 | 0.45 | 0.61 |
Price / Net Operating Revenue (X) | 0.15 | 0.19 | 0.16 | 0.15 | 0.13 |
EarningsYield | -1.60 | -0.96 | 0.05 | -1.31 | -0.13 |
After reviewing the key financial ratios for Aplab Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 5. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For Diluted EPS (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 5. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For Cash EPS (Rs.), as of Mar 16, the value is -31.37. This value is below the healthy minimum of 3. It has decreased from -24.41 (Mar 15) to -31.37, marking a decrease of 6.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is -8.81. It has decreased from 26.34 (Mar 15) to -8.81, marking a decrease of 35.15.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is -8.77. It has decreased from 26.39 (Mar 15) to -8.77, marking a decrease of 35.16.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 142.20. It has decreased from 149.14 (Mar 15) to 142.20, marking a decrease of 6.94.
- For PBDIT / Share (Rs.), as of Mar 16, the value is -8.88. This value is below the healthy minimum of 2. It has decreased from -3.06 (Mar 15) to -8.88, marking a decrease of 5.82.
- For PBIT / Share (Rs.), as of Mar 16, the value is -12.66. This value is below the healthy minimum of 0. It has decreased from -7.08 (Mar 15) to -12.66, marking a decrease of 5.58.
- For PBT / Share (Rs.), as of Mar 16, the value is -35.14. This value is below the healthy minimum of 0. It has decreased from -28.33 (Mar 15) to -35.14, marking a decrease of 6.81.
- For Net Profit / Share (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 2. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 2. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For PBDIT Margin (%), as of Mar 16, the value is -6.24. This value is below the healthy minimum of 10. It has decreased from -2.05 (Mar 15) to -6.24, marking a decrease of 4.19.
- For PBIT Margin (%), as of Mar 16, the value is -8.90. This value is below the healthy minimum of 10. It has decreased from -4.74 (Mar 15) to -8.90, marking a decrease of 4.16.
- For PBT Margin (%), as of Mar 16, the value is -24.70. This value is below the healthy minimum of 10. It has decreased from -18.99 (Mar 15) to -24.70, marking a decrease of 5.71.
- For Net Profit Margin (%), as of Mar 16, the value is -24.71. This value is below the healthy minimum of 5. It has decreased from -19.05 (Mar 15) to -24.71, marking a decrease of 5.66.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is -24.71. This value is below the healthy minimum of 8. It has decreased from -19.05 (Mar 15) to -24.71, marking a decrease of 5.66.
- For Return on Networth / Equity (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -112.18 (Mar 15) to 0.00, marking an increase of 112.18.
- For Return on Capital Employeed (%), as of Mar 16, the value is -87.40. This value is below the healthy minimum of 10. It has decreased from -8.90 (Mar 15) to -87.40, marking a decrease of 78.50.
- For Return On Assets (%), as of Mar 16, the value is -13.14. This value is below the healthy minimum of 5. It has decreased from -11.07 (Mar 15) to -13.14, marking a decrease of 2.07.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.58 (Mar 15) to 0.00, marking a decrease of 0.58.
- For Total Debt / Equity (X), as of Mar 16, the value is -16.98. This value is within the healthy range. It has decreased from 5.50 (Mar 15) to -16.98, marking a decrease of 22.48.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.54. It has increased from 0.53 (Mar 15) to 0.54, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 0.39. This value is below the healthy minimum of 1.5. It has decreased from 0.57 (Mar 15) to 0.39, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 16, the value is 0.24. This value is below the healthy minimum of 1. It has increased from 0.20 (Mar 15) to 0.24, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 16, the value is 1.65. This value is below the healthy minimum of 4. It has increased from 1.25 (Mar 15) to 1.65, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 16, the value is -0.39. This value is below the healthy minimum of 3. It has decreased from -0.14 (Mar 15) to -0.39, marking a decrease of 0.25.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -0.56. This value is below the healthy minimum of 3. It has decreased from -0.33 (Mar 15) to -0.56, marking a decrease of 0.23.
- For Enterprise Value (Cr.), as of Mar 16, the value is 88.89. It has increased from 87.10 (Mar 15) to 88.89, marking an increase of 1.79.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 1.25. This value is within the healthy range. It has increased from 1.17 (Mar 15) to 1.25, marking an increase of 0.08.
- For EV / EBITDA (X), as of Mar 16, the value is -20.01. This value is below the healthy minimum of 5. It has increased from -56.88 (Mar 15) to -20.01, marking an increase of 36.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 15) to 0.15, marking a decrease of 0.04.
- For Price / BV (X), as of Mar 16, the value is -2.24. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 15) to -2.24, marking a decrease of 3.40.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 15) to 0.15, marking a decrease of 0.04.
- For EarningsYield, as of Mar 16, the value is -1.60. This value is below the healthy minimum of 5. It has decreased from -0.96 (Mar 15) to -1.60, marking a decrease of 0.64.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aplab Ltd:
- Net Profit Margin: -24.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -87.4% (Industry Average ROCE: 8.82%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 2.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.24
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 164 (Industry average Stock P/E: 164)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -16.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -24.71%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Instrumentation & Process Control | Plot No. 12, TTC Industrial Area Thane Belapur Road, Digha, New Mumbai Maharashtra 400708 | response@aplab.com www.aplab.com |
Management | |
---|---|
Name | Position Held |
Mrs. Amrita P Deodhar | Chairperson & Managing Director |
Mr. S K Hajela | Additional Director |
Mr. Sanjay N Mehta | Independent Director |
Mrs. Uma Balakrishnan | Independent Director |
FAQ
What is the intrinsic value of Aplab Ltd?
Aplab Ltd's intrinsic value (as of 10 October 2025) is 16.34 which is 78.16% lower the current market price of 74.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹165 Cr. market cap, FY2025-2026 high/low of 84.4/28.2, reserves of ₹-2.19 Cr, and liabilities of 69.96 Cr.
What is the Market Cap of Aplab Ltd?
The Market Cap of Aplab Ltd is 165 Cr..
What is the current Stock Price of Aplab Ltd as on 10 October 2025?
The current stock price of Aplab Ltd as on 10 October 2025 is 74.8.
What is the High / Low of Aplab Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aplab Ltd stocks is 84.4/28.2.
What is the Stock P/E of Aplab Ltd?
The Stock P/E of Aplab Ltd is 164.
What is the Book Value of Aplab Ltd?
The Book Value of Aplab Ltd is 4.14.
What is the Dividend Yield of Aplab Ltd?
The Dividend Yield of Aplab Ltd is 0.00 %.
What is the ROCE of Aplab Ltd?
The ROCE of Aplab Ltd is 8.82 %.
What is the ROE of Aplab Ltd?
The ROE of Aplab Ltd is 2.95 %.
What is the Face Value of Aplab Ltd?
The Face Value of Aplab Ltd is 10.0.